In a patient with a large intracavitary uterine mass identified on transvaginal ultrasound and an initially enlarged uterus, the uterine size has decreased after five months; does this indicate that the mass has prolapsed into the uterine cavity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Decreased Uterine Size Does Not Necessarily Indicate Mass Prolapse into the Cavity

A decrease in uterine size over 5 months in a patient with a large intracavitary uterine mass most likely represents spontaneous fibroid degeneration, infarction, or natural size reduction rather than prolapse into the uterine cavity. Prolapse would typically maintain or potentially increase overall uterine dimensions rather than decrease them.

Understanding the Natural History of Intracavitary Masses

The observed decrease in uterine size suggests several more likely scenarios than prolapse:

Most Probable Explanations:

Spontaneous fibroid degeneration or size reduction is a well-documented phenomenon. Fibroids can undergo various types of degeneration (hyaline, cystic, red degeneration) that result in decreased size over time 1. This is particularly common with larger fibroids and can occur without intervention.

Natural fibroid involution can occur, especially in certain hormonal states or as fibroids outgrow their blood supply. The ACR guidelines note that fibroid size reduction commonly occurs within the first 6 months following devascularization, though this typically refers to post-treatment scenarios 1.

Why Prolapse is Less Likely:

Intracavitary prolapse would not typically cause overall uterine size reduction. If a mass were prolapsing into the uterine cavity or through the cervix, you would expect:

  • Maintained or increased uterine dimensions initially
  • Visible or palpable mass at the cervical os on examination
  • Associated symptoms (bleeding, cramping, discharge, sensation of something protruding)
  • The mass would still occupy space, just in a different location

Recommended Diagnostic Approach

Perform repeat transvaginal ultrasound (TVUS) combined with transabdominal ultrasound (TAUS) to characterize the current state of the mass 1. Specifically assess:

  • Current fibroid location and dimensions - Document whether the mass is still intracavitary, has changed position, or shows signs of expulsion
  • Echogenicity changes - Look for heterogeneous increased echogenicity suggesting degeneration, or hypoechoic areas indicating cystic change 1
  • Presence of gas - May indicate infarction/necrosis 1
  • Vascular assessment with color Doppler - Decreased or absent vascularity suggests devascularization or degeneration 1
  • Endometrial cavity assessment - Determine if the cavity is now empty or if mass components remain

Consider Advanced Imaging if Needed:

MRI pelvis with gadolinium contrast should be obtained if ultrasound findings are equivocal or if you need to:

  • Better characterize the degree of fibroid infarction/devascularization 1
  • Assess for complications (infection, abscess formation)
  • Rule out alternative diagnoses including malignancy
  • Plan potential intervention

Clinical Correlation is Essential

Assess for symptoms that would accompany fibroid expulsion or prolapse:

  • Heavy vaginal bleeding or discharge
  • Severe cramping or labor-like pains
  • Sensation of vaginal fullness or protrusion
  • Fever (suggesting infection of degenerating fibroid)

Physical examination findings to document:

  • Cervical os appearance - any visible tissue or mass
  • Uterine size and tenderness on bimanual exam
  • Presence of discharge or bleeding

Important Caveats

Fibroid expulsion occurs in only 2.2% to 7.7% of cases and is specifically associated with intracavitary devascularized fibroids, typically following interventions like uterine fibroid embolization 1. Spontaneous expulsion without prior intervention is uncommon but can occur with submucosal fibroids.

Rapid size changes warrant careful evaluation to exclude:

  • Sarcomatous degeneration (though rare, presents with rapid growth typically, not shrinkage)
  • Infection of degenerating fibroid (pyomyoma)
  • Pregnancy-related changes if applicable

If the patient is asymptomatic, the size reduction likely represents benign involution, but documentation with imaging is still warranted to establish a new baseline and guide future surveillance 1.

References

Guideline

acr appropriateness criteria® fibroids.

Journal of the American College of Radiology, 2022

Related Questions

Can I order a Cologuard test for a patient presenting with blood in the stool?
Which suture materials and sizes are optimal for different wound types (e.g., superficial clean lacerations, deeper moderate‑tension wounds, contaminated or high‑tension wounds, and fascia or tendon repairs)?
In a 72‑year‑old smoker undergoing low‑dose computed tomography (LDCT) screening who now has a new 6 × 9 mm right upper‑lobe nodule minimally avid on positron emission tomography (PET) and a new 3 mm left upper‑lobe nodule, with other stable nodules, should these nodules be followed with yearly imaging or a more frequent surveillance protocol?
Can hair transplant surgery affect the ventromedial prefrontal cortex in a patient?
What are the common laboratory abnormalities after massive transfusion (≥10 units packed red cells within 24 hours)?
In a young‑to‑middle‑aged adult male with borderline low total testosterone, low‑normal free testosterone, mildly elevated creatine kinase, isolated mild AST elevation, low‑normal white blood cell count, high LDL‑cholesterol and markedly elevated lipoprotein(a), what are the appropriate management recommendations?
What is an evidence‑based enhanced recovery after surgery (ERAS) protocol, including pre‑operative, intra‑operative, and postoperative recommendations?
What is the recommended treatment regimen for extrapulmonary tuberculosis in an immunocompromised patient?
What are the indications for ureteric stenting in acute pyelonephritis?
In a patient at high risk for invasive aspergillosis (e.g., prolonged neutropenia, hematologic malignancy, stem‑cell or organ transplant, or high‑dose corticosteroids) with clinical signs such as fever or pulmonary infiltrates, when should I order a serum galactomannan assay, how do I interpret the results, and what antifungal therapy is recommended?
What is the appropriate workup for microcytic anemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.